{"DataElement":{"publicId":"7802173","version":"2","preferredName":"Biospecimen Test or Examination Sponsor Defined Name","preferredDefinition":"The name of the biospecimen test or examination used to obtain the measurement or finding, as defined by the sponsor.","longName":"BSTEST_SPD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7044690","version":"1","preferredName":"Biospecimen Domain Test Name","preferredDefinition":"A findings domain that documents biospecimen handling information._The literal identifier of an examination.","longName":"7044577v1.0:6813511v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"7044577","version":"1","preferredName":"Biospecimen Domain","preferredDefinition":"A findings domain that documents biospecimen handling information.","longName":"C111137","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen Domain","conceptCode":"C111137","definition":"A findings domain that documents biospecimen handling information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"96B3551B-DFE9-3B2B-E053-F662850A0442","latestVersionIndicator":"Yes","beginDate":"2019-11-06","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-11-06","modifiedBy":"ONEDATA","dateModified":"2019-11-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6813511","version":"1","preferredName":"Test Name","preferredDefinition":"The literal identifier of an examination.","longName":"C82541","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Test Name","conceptCode":"C82541","definition":"The literal identifier of an examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8CCDB264-F182-019E-E053-F662850A0608","latestVersionIndicator":"Yes","beginDate":"2019-07-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-07-03","modifiedBy":"ONEDATA","dateModified":"2019-07-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2182370","version":"1","preferredName":"Procedures","preferredDefinition":"Tests, examinations, evaluations used to determine a subject's status or response to intervention.  ","longName":"PROCEDURES","context":"CCR","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7049CF8-1252-211C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-04-01","endDate":null,"createdBy":"DWARZEL","dateCreated":"2004-04-01","modifiedBy":"REEVESD","dateModified":"2004-09-24","changeDescription":"Created initially to support CCR value domain for CTMS. ","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96C0CBE5-0414-194E-E053-F662850A279F","latestVersionIndicator":"Yes","beginDate":"2019-11-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-11-07","modifiedBy":"TAYLORT","dateModified":"2020-06-03","changeDescription":"6-3-20 released/MM. 11/7/19 tmt created for Seed Study.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7802154","version":"1.1","preferredName":"Biospecimen Test Name Clinical Study Sponsor Defined Name","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products._The literal identifier of an examination._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]_Clearly characterized or delimited._The words or language units by which a thing is known.","longName":"BSTEST_SPD","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Tumor Protein Concentration","valueDescription":"Neoplasm Protein Concentration","ValueMeaning":{"publicId":"7802156","version":"1","preferredName":"Neoplasm Protein Concentration","longName":"7802156","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.: A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.: The quantity of a substance per unit volume or weight; a measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Protein","conceptCode":"C17021","definition":"A group of complex organic macromolecules composed of one or more chains (linear polymers) of alpha-L-amino acids linked by peptide bonds and ranging in size from a few thousand to over 1 million Daltons. Proteins are fundamental genetically encoded components of living cells with specific structures and functions dictated by amino acid sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Concentration","conceptCode":"C41185","definition":"The quantity of a substance per unit volume or weight; a measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-E970-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-18EA-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"Cell Count","valueDescription":"Cell Count","ValueMeaning":{"publicId":"2915742","version":"1","preferredName":"Cell Count","longName":"2915742","preferredDefinition":"A procedure to determine the number of cells in a sample. Also used to mean the result of such a procedure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cell Count","conceptCode":"C48938","definition":"A procedure to determine the number of cells in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6E33206B-57B1-2E5D-E040-BB89AD434538","latestVersionIndicator":"Yes","beginDate":"2009-07-08","endDate":null,"createdBy":"UMLLOADER_CANANOLPRD","dateCreated":"2009-07-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-18F4-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"cfDNA % of total","valueDescription":"Circulating Cell-Free DNA Percentage Total","ValueMeaning":{"publicId":"7802157","version":"1","preferredName":"Circulating Cell-Free DNA Percentage Total","longName":"7802157","preferredDefinition":"DNA that is found in blood plasma and is not associated with cells in the circulation.: A fraction or ratio with 100 understood as the denominator.: Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Cell-Free DNA","conceptCode":"C128274","definition":"DNA found in blood plasma and other bodily fluids that is not associated with cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-E9AC-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-18FE-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"cfDNA Yield","valueDescription":"Circulating Cell-Free DNA Output","ValueMeaning":{"publicId":"7802158","version":"1","preferredName":"Circulating Cell-Free DNA Output","longName":"7802158","preferredDefinition":"DNA that is found in blood plasma and is not associated with cells in the circulation.: Anything coming out of a system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Cell-Free DNA","conceptCode":"C128274","definition":"DNA found in blood plasma and other bodily fluids that is not associated with cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Output","conceptCode":"C47906","definition":"Anything coming out of a system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-E9D2-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-1908-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"cfDNA Concentration","valueDescription":"Circulating Cell-Free DNA Concentration","ValueMeaning":{"publicId":"7802159","version":"1","preferredName":"Circulating Cell-Free DNA Concentration","longName":"7802159","preferredDefinition":"DNA that is found in blood plasma and is not associated with cells in the circulation.: The quantity of a substance per unit volume or weight; a measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Circulating Cell-Free DNA","conceptCode":"C128274","definition":"DNA found in blood plasma and other bodily fluids that is not associated with cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Concentration","conceptCode":"C41185","definition":"The quantity of a substance per unit volume or weight; a measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-E9F8-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-1912-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"Total volume of plasma","valueDescription":"Total Volume Plasma","ValueMeaning":{"publicId":"7802160","version":"1","preferredName":"Total Volume Plasma","longName":"7802160","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.: The amount of three dimensional space occupied by an object or the capacity of a space or container.: Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Volume","conceptCode":"C25335","definition":"The amount of three dimensional space occupied by an object or the capacity of a space or container.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Plasma","conceptCode":"C13356","definition":"Plasma is the fluid (noncellular) portion of the circulating blood, as distinguished from the serum that is the fluid portion of the blood obtained by removal of the fibrin clot and blood cells after coagulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-EA1F-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-191C-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"RNA %DV200","valueDescription":"Ribonucleic Acid Percentage DV200 Assay","ValueMeaning":{"publicId":"7802161","version":"1","preferredName":"Ribonucleic Acid Percentage DV200 Assay","longName":"7802161","preferredDefinition":"Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.: A fraction or ratio with 100 understood as the denominator.: A method to determine the quality of RNA obtained from a sample. DV200 evaluates the percentage of fragments of greater than 200 nucleotides.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ribonucleic Acid","conceptCode":"C812","definition":"Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"DV200 Assay","conceptCode":"C183241","definition":"A method to determine the quality of RNA obtained from a sample. DV200 evaluates the percentage of fragments of greater than 200 nucleotides.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-EA46-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-1926-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"RNA RIN","valueDescription":"RNA Integrity Number","ValueMeaning":{"publicId":"7802162","version":"1","preferredName":"RNA Integrity Number","longName":"7802162","preferredDefinition":"A numerical assessment of the integrity of RNA based on the entire electrophoretic trace of the RNA sample, including the presence or absence of degradation products.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"RNA Integrity Number","conceptCode":"C63637","definition":"A numerical assessment of the integrity of RNA based on the entire electrophoretic trace of the RNA sample, including the presence or absence of degradation products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-EA69-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-1930-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"RNA Yield","valueDescription":"Ribonucleic Acid Output","ValueMeaning":{"publicId":"7802163","version":"1","preferredName":"Ribonucleic Acid Output","longName":"7802163","preferredDefinition":"Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.: Anything coming out of a system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ribonucleic Acid","conceptCode":"C812","definition":"Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Output","conceptCode":"C47906","definition":"Anything coming out of a system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-EA8F-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-193A-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"RNA Concentration","valueDescription":"Ribonucleic Acid Concentration","ValueMeaning":{"publicId":"7802164","version":"1","preferredName":"Ribonucleic Acid Concentration","longName":"7802164","preferredDefinition":"Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.: The quantity of a substance per unit volume or weight; a measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ribonucleic Acid","conceptCode":"C812","definition":"Single-stranded long chain of nucleotides containing ribose. It is the end product of DNA transcription by the enzyme RNA polymerase. It is essential in protein synthesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Concentration","conceptCode":"C41185","definition":"The quantity of a substance per unit volume or weight; a measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-EAB2-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-1944-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"Genotype Match","valueDescription":"Genotype Match","ValueMeaning":{"publicId":"7802155","version":"1","preferredName":"Genotype Match","longName":"7802155","preferredDefinition":"The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype.: An exact duplicate; coinciding in characteristics; similar or consistent.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Genotype","conceptCode":"C16631","definition":"The genetic constitution of an organism or cell, as distinct from its expressed features or phenotype.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Match","conceptCode":"C54116","definition":"An exact duplicate; coinciding in characteristics; similar or consistent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-E949-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-18E0-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"DNA Quality","valueDescription":"DNA Quality","ValueMeaning":{"publicId":"8032190","version":"1","preferredName":"DNA Quality","longName":"8032190","preferredDefinition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.: An essential and distinguishing attribute of something or someone; a degree or grade of excellence or worth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA","conceptCode":"C449","definition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Quality","conceptCode":"C25283","definition":"An essential and distinguishing attribute of something or someone; a degree or grade of excellence or worth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D796DAE7-19E5-17C2-E053-4EBD850AE182","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-19FE-17C2-E053-4EBD850AE182","beginDate":"2022-02-09","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"DNA DIN","valueDescription":"DNA Integrity Number","ValueMeaning":{"publicId":"7802170","version":"1","preferredName":"DNA Integrity Number","longName":"7802170","preferredDefinition":"An assessment of the amount of fragmentation in a genomic DNA sample. It is derived by an algorithm that assesses the distribution of signal across the size range and generates a calculated integrity number.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA Integrity Number","conceptCode":"C183240","definition":"An assessment of the amount of fragmentation in a genomic DNA sample. It is derived by an algorithm that assesses the distribution of signal across the size range and generates a calculated integrity number.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-EB95-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-1980-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"DNA Yield","valueDescription":"DNA Output","ValueMeaning":{"publicId":"7802171","version":"1","preferredName":"DNA Output","longName":"7802171","preferredDefinition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.: Anything coming out of a system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA","conceptCode":"C449","definition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Output","conceptCode":"C47906","definition":"Anything coming out of a system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-EBBB-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-198A-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"},{"value":"DNA Concentration","valueDescription":"DNA Concentration","ValueMeaning":{"publicId":"7802172","version":"1","preferredName":"DNA Concentration","longName":"7802172","preferredDefinition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.: The quantity of a substance per unit volume or weight; a measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA","conceptCode":"C449","definition":"A long linear double-stranded polymer formed from nucleotides attached to a deoxyribose backbone and found in the nucleus of a cell; associated with the transmission of genetic information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Concentration","conceptCode":"C41185","definition":"The quantity of a substance per unit volume or weight; a measure of the amount of substance present in a unit amount of mixture, particularly, the amount of solute dissolved in a solvent. The amounts can be expressed as moles, masses, volumes, or parts.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-EBE1-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D796DAE7-1994-17C2-E053-4EBD850AE182","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"ONEDATA","dateModified":"2022-02-09","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7802153","version":"1","preferredName":"Biospecimen Test Name Clinical Study Sponsor Defined Name","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:The literal identifier of an examination.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:The words or language units by which a thing is known.","longName":"7802153v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen","conceptCode":"C70699","definition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Test Name","conceptCode":"C82541","definition":"The literal identifier of an examination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CFE5BB2D-E923-326F-E053-4EBD850A09DD","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2021-11-03","modifiedBy":"ONEDATA","dateModified":"2021-11-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D796DAE7-18CA-17C2-E053-4EBD850AE182","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"SOKKERL","dateModified":"2022-02-18","changeDescription":"11/3/2021 created for Biospecimen Tracking, wz. Added and Deleted PVs per Melissa request. 2/9/22 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Biospecimen test name","type":"Preferred Question Text","description":"Biospecimen test name","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Biospecimen Test Name","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7998EAE-FCAE-5D8F-E053-4EBD850A1E63","latestVersionIndicator":"Yes","beginDate":"2021-11-03","endDate":null,"createdBy":"SOKKERL","dateCreated":"2022-02-09","modifiedBy":"SOKKERL","dateModified":"2022-02-18","changeDescription":"11/3/2021 created for Biospecimen Tracking, wz. Versioned CDE and VD Ls 2/9/2022","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}